Open Orphan Plc (GB:HVO) has released an update.
hVIVO plc, a leading contract research organization specializing in infectious and respiratory disease trials, is set to showcase its expertise at the Jefferies Healthcare Conference in London. CEO Yamin ‘Mo’ Khan will present the company’s innovations on November 19, 2024, highlighting hVIVO’s cutting-edge facilities and pioneering human challenge models. This event underscores hVIVO’s pivotal role in the healthcare sector, attracting attention from global biopharma giants and investors alike.
For further insights into GB:HVO stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
